Items where authors include "Watson, P"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Dighe, SG, Chen, J, Yan, L et al. (70 more authors) (2020) Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma. Carcinogenesis. ISSN 0143-3334

Clarke, EA, Watson, P, Freeston, JE orcid.org/0000-0003-0358-338X et al. (3 more authors) (2019) Assessing arthritis in the context of cystic fibrosis. Pediatric Pulmonology, 54 (6). pp. 770-777. ISSN 8755-6863

Buas, MF, He, Q, Johnson, LG et al. (37 more authors) (2017) Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, 66 (10). pp. 1739-1737. ISSN 0017-5749

Pincus, T, Anwar, S, McCracken, LM et al. (8 more authors) (2015) Delivering an Optimised Behavioural Intervention (OBI) to people with low back pain with high psychological risk; results and lessons learnt from a feasibility randomised controlled trial of Contextual Cognitive Behavioural Therapy (CCBT) vs. Physiotherapy. BMC Musculoskeletal Disorders, 16. 147. pp. 1-11. ISSN 1471-2474

Palles, C, Chegwidden, L, Li, X et al. (95 more authors) (2015) Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus. Gastroenterology, 148 (2). pp. 367-378. ISSN 0016-5085

Palles, C, Chegwidden, L, Li, X et al. (95 more authors) (2015) Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus. Gastroenterology, 148 (2). pp. 367-378. ISSN 0016-5085

Proceedings Paper

Ibrahim, MET, Clarke, E, Martin, K et al. (5 more authors) (2018) Cystic fibrosis and inflammatory arthritis requiring immunosuppression: a worrying combination? In: Annals of the Rheumatic Diseases. EULAR 2018: Annual European Congress of Rheumatology, 13-16 Jun 2018, Amsterdam, Netherlands. BMJ Publishing Group , p. 1679.

Clarke, EA, Ibrahim, M, Martin, K et al. (5 more authors) (2018) P130 Immunosuppression in cystic fibrosis: how worried should we be? In: Journal of Cystic Fibrosis 2018;17(3):S95–S96. 41ST European Cystic Fibrosis Society Conference, Belgrade, Serbia, 06-09 Jun 2018. Elsevier , S95-S96.

Clarke, EA, Taylor, J, Horsley, AR et al. (7 more authors) (2018) Musculoskeletal symptoms represent a significant burden for adults with cystic fibrosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, UK. Oxford Academic .